Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment

Paolo Fagone, Emanuela Mazzon, Santa Mammana, Roberto Di Marco, Flaminia Spinasanta, Maria Sofia Basile, Maria Cristina Petralia, Placido Bramanti, Ferdinando Nicoletti, Katia Mangano

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Identification of CD4<sup>+</sup> T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds